A novel mutation in the tyrosine kinase domain of <it>ERBB2 </it>in hepatocellular carcinoma
<p>Abstract</p> <p>Background</p> <p>Several studies showed that gain-of-function somatic mutations affecting the catalytic domain of <it>EGFR </it>in non-small cell lung carcinomas were associated with response to gefitinib and erlotinib, both <it>EGF...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2006-12-01
|
| Series: | BMC Cancer |
| Online Access: | http://www.biomedcentral.com/1471-2407/6/278 |